Cargando…

LncRNA BC promotes lung adenocarcinoma progression by modulating IMPAD1 alternative splicing

BACKGROUND: The therapeutic value of targeted therapies in patients with lung cancer is reduced when tumours acquire secondary resistance after an initial period of successful treatment. However, the molecular events behind the resistance to targeted therapies in lung cancer remain largely unknown....

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Qi Wen, Cai, Qian Qian, Yang, Ying, Dong, Shu, Liu, Yuan Yuan, Chen, Zhong Yi, Kang, Chun Lan, Qi, Bing, Dong, Yi Wei, Wu, Wei, Zhuang, Li Ping, Shen, Ye Hua, Meng, Zhi Qiang, Wu, Xing Zhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845120/ https://www.ncbi.nlm.nih.gov/pubmed/36650118 http://dx.doi.org/10.1002/ctm2.1129

Ejemplares similares

The pan-cancer lncRNA PLANE regulates an alternative splicing program to promote cancer pathogenesis
por: Teng, Liu, et al.
Publicado: (2021)

Circulating lncRNA BC030099 Increases in Preeclampsia Patients
por: Sun, Yuhong, et al.
Publicado: (2019)

Effect of lncRNA-BC200 on proliferation and migration of liver cancer cells in vitro and in vivo
por: Tan, Ni, et al.
Publicado: (2020)

An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021)

IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
por: Bajaj, Rakhee, et al.
Publicado: (2020)

LncRNA BC032020 suppresses the survival of human pancreatic ductal adenocarcinoma cells by targeting ZNF451
por: Zhang, Zhipeng, et al.
Publicado: (2018)

LncRNA AY promotes hepatocellular carcinoma metastasis by stimulating ITGAV transcription
por: Kang, Chun Lan, et al.
Publicado: (2019)

LncRNA-BC069792 suppresses tumor progression by targeting KCNQ4 in breast cancer
por: Zhang, Yunxiang, et al.
Publicado: (2023)

LncRNA Ctcflos orchestrates transcription and alternative splicing in thermogenic adipogenesis
por: Bast‐Habersbrunner, Andrea, et al.
Publicado: (2021)

LncRNA FLAIL affects alternative splicing and represses flowering in Arabidopsis
por: Jin, Yu, et al.
Publicado: (2023)

A Prognostic Cuproptosis-Related LncRNA Signature for Colon Adenocarcinoma
por: Zhong, Like, et al.
Publicado: (2023)

LncRNA BC200 Promotes Esophageal Squamous Cell Cancer Migration and Invasion and Can Regulate ATF4 Expression
por: Zhao, Ruihua, et al.
Publicado: (2020)

Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma
por: Lyu, Hao, et al.
Publicado: (2023)

Breast metastatic tumors in lung can be substituted by lung-derived malignant cells transformed by alternative splicing H19 lncRNA
por: Xu, Jin Biao, et al.
Publicado: (2023)

Identification of LncRNA Prognostic Signature Associated With Genomic Instability in Pancreatic Adenocarcinoma
por: Zhu, Jinfeng, et al.
Publicado: (2022)

Construction of a model to predict the prognosis of patients with cholangiocarcinoma using alternative splicing events
por: Wu, Hua-Yu, et al.
Publicado: (2019)

Alternative splicing modulation mediated by G-quadruplex structures in MALAT1 lncRNA
por: Ghosh, Arpita, et al.
Publicado: (2021)

Heterogeneous expression of alternatively spliced lncRNA mediates vascular smooth cell plasticity
por: Mayner, Jaimie M., et al.
Publicado: (2023)

Construction of disulfidptosis-related lncRNA signature for predicting the prognosis and immune escape in colon adenocarcinoma
por: Chen, Pan, et al.
Publicado: (2023)

Full-Length Transcriptome Sequencing Reveals Alternative Splicing and lncRNA Regulation during Nodule Development in Glycine max
por: Liu, Jing, et al.
Publicado: (2022)

Novel lncRNA UPLA1 mediates tumorigenesis and prognosis in lung adenocarcinoma
por: Han, Xiaoyang, et al.
Publicado: (2020)

Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis
por: Bajaj, Rakhee, et al.
Publicado: (2022)

Comprehensive Network Analysis Reveals Alternative Splicing-Related lncRNAs in Hepatocellular Carcinoma
por: Wang, Junqing, et al.
Publicado: (2020)

LncRNA BCLET variant confers bladder cancer susceptibility through alternative splicing of MSANTD2 exon 1
por: Liu, Hanting, et al.
Publicado: (2023)

Signature of gene aberrant alternative splicing events in pancreatic adenocarcinoma prognosis
por: Yao, Jun, et al.
Publicado: (2021)

Small Protein Hidden in lncRNA LOC90024 Promotes “Cancerous” RNA Splicing and Tumorigenesis
por: Meng, Nan, et al.
Publicado: (2020)

Role of MicroRNA, LncRNA, and Exosomes in the Progression of Osteoarthritis: A Review of Recent Literature
por: Xie, Fang, et al.
Publicado: (2020)

Joint analysis of lncRNA m(6)A methylome and lncRNA/mRNA expression profiles in gastric cancer
por: Lv, Zhi, et al.
Publicado: (2020)

Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
por: Qi, Xiangjun, et al.
Publicado: (2021)

The Gut Microbiota Dysbiosis in Preeclampsia Contributed to Trophoblast Cell Proliferation, Invasion, and Migration via lncRNA BC030099/NF-κB Pathway
por: Tang, Rong, et al.
Publicado: (2022)

RBM10 regulates alternative splicing of lncRNA Neat1 to inhibit the invasion and metastasis of NSCLC
por: Cong, Shan, et al.
Publicado: (2022)

Retraction and replacement of ‘Alternative splicing modulation mediated by G-quadruplex structures in MALAT1 lncRNA’
Publicado: (2023)

Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma
por: Ye, Zai-Sheng, et al.
Publicado: (2021)

LncRNA LINC01116 Contributes to Cisplatin Resistance in Lung Adenocarcinoma
por: Wang, Junbin, et al.
Publicado: (2020)

Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma
por: Chang, Ya-Sian, et al.
Publicado: (2020)

Identification and Validation of a Novel Six-lncRNA-Based Prognostic Model for Lung Adenocarcinoma
por: Yang, Lingge, et al.
Publicado: (2022)

Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis
por: Singh, R, et al.
Publicado: (2016)

Risk coefficient model of necroptosis-related lncRNA in predicting the prognosis of patients with lung adenocarcinoma
por: Chen, HuiWei, et al.
Publicado: (2022)

LncReg: a reference resource for lncRNA-associated regulatory networks
por: Zhou, Zhong, et al.
Publicado: (2015)

A risk stratification and prognostic prediction model for lung adenocarcinoma based on aging-related lncRNA
por: Chen, HuiWei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_q02b9qcu2g4aj1m3khq3nq9vjo